Newnal的封面图片

关于我们

For the last decade, Blockchain Labs (BCL) has been developing blockchain-based infrastructure that operates without cryptocurrency to offer groundbreaking security and scalability for sensitive and proprietary data. BCL's globally patented technology, InfraBlockchain?, enables secure, transparent, cost-effective applications for various industries. In 2020, BCL developed the COOV app, the world's first blockchain-based vaccine pass, accepted in 120+ countries globally and used by over 43 million people, 30+ million times a day. After raising a Series A in 2022, BCL embarked on its most ambitious project, Newnal. Newnal offers unprecedented precision and privacy in generative AI by ensuring sensitive data's utmost integrity, security, and reliability. Newnal redefines how data is handled – transforming the landscape of B2B and B2C AI applications where trust and precision are non-negotiable. Blockchain Labs is headquartered in Seoul and has an office in San Francisco. For more information, visit bc-labs.net/en

网站
https://www.newnal.com
所属行业
科技、信息和网络
规模
51-200 人
总部
Seoul
类型
私人持股
创立
2013
领域
Blockchain、Web3和AI

地点

Newnal员工

动态

  • 查看Newnal的组织主页

    810 位关注者

    ?? PoT Consensus Algorithm Secures U.S. Patent ?? Blockchain Lab’s InfraBlockchain core technology, Proof-of-Transaction (PoT) consensus algorithm, has been officially registered with the USPTO and awarded a patent certificate. This achievement comes on the heels of our previous patent success in Korea. - Application Number: 17/040,724? - Title of Invention: BLOCKCHAIN SYSTEM TO WHICH PROOF-OF-TRANSACTION CONSENSUS ALGORITHM IS APPLIED, AND METHOD THEREFORE - Patent Number & Publication Date: 11636450 / 04.25.2023 ??World’s first cryptocurrency-less public blockchain network ??Read more about #PoT below https://lnkd.in/g4sWYYSj

相似主页

查看职位